Drugs Control Dept Collects Details On Covid Test Kit Buyers

Mangalurub : The Dakshina Kannada administration has started collecting details from drugstores of those who buy Covid-19 test kits, fearing that these buyers may escape quarantine if they go unaccounted for after an infection.

The collection of information started on Monday, under the direction of the district drugs control department.

A senior department official said the contact details of the buyers will be given to the health department.

Proprietors of several drug stores and pharmacy businesses said they had got the circular. However, district health officer Dr Kishore Kumar M pointed to a problem that could arise after the data collection. Kumar said that through the additional drug controller, who is the inspecting authority, names, addresses and phone numbers of customers who have purchased these kits are being collected. If a buyer tests positive, he is expected to update the results on an app, that will reflect on the ICMR website. However, there was no mechanism in place to check if the results were indeed being updated, the district health officer said.

Herald Monteiro, the proprietor of Health Care Medicals, told TOI he had got a call from the drugs control department, asking for the details of customers. On Tuesday, he sold about 15 kits to a social services organisation, he said.

A representative from Ganesh Medicals said that the demand for the kits had increased in the last 15 days. “We are selling an average of 20-25 kits per day, costing Rs 250,” he said.

Manohar Shetty, the managing director of the Sai Radha Group, said the sales are not as high compared to Mumbai or Bengaluru. “About 8-10 home testing kits are sold per day. These days, the awareness level is high, and people get themselves treated for cold and fever immediately, due to which recovery is high,” he said.

Mohammed Kunhi, the proprietor of Unity Medicals, said the kits were sold for the first time in the second wave. “We got complaints that the results are not accurate. Whenever a customer asks for a kit, I suggest they go to a nearby public health centre and opt for an RT-PCR test. We have sold only about two kits so far,” he said. He added that he too had received the circular from the drugs control department asking for buyers’ details.

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre